07:00 , Oct 7, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer MicroRNA-380-5p (miR-380-5p) Studies in patient samples and in mice suggest that antagonizing miR-380-5p could help treat neuroblastoma. About 76%...
07:00 , Oct 7, 2010 |  BC Innovations  |  Targets & Mechanisms

An miRNA boost for p53

Although many studies have shown that altered expression of one or more microRNAs is associated with cancer, they have not shown that the miRNAs could be therapeutically targeted with a drug-like molecule. Now, U.S. and...